The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Guna-Anti Il 1
Anti-Interleukin-1.alpha. Immunoglobulin G Rabbit- Canakinumab · ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT 4 [hp_C]/30mL; CANAKINUMAB 4 [hp_C]/30mL · Solution/ Drops · Oral · Guna spa
NDC 17089-0398-18 · 1 BOTTLE, DROPPER in 1 BOX / 30 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Anti-Interleukin-1.alpha. Immunoglobulin G Rabbit- Canakinumab (Solution/ Drops)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Guna spa | ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT 4 [hp_C]/30mL; CANAKINUMAB 4 [hp_C]/30mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Guna-Anti Il 1 — NDC 17089-0398-18," retrieved September 3, 2026, https://drugdashboards.com/drug/17089039818.
Free to cite with attribution — see how the data is put together.